Showing results (451-460 of 533) with videos related to
Sort By:
Pageof 54
Cephalalgia : an International Journal of Headache|November 26, 2020
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implicationsPeter J Goadsby, Andrew M Blumenfeld, Richard B Lipton, et al.The New England Journal of Medicine|November 25, 2017
Fremanezumab for the Preventive Treatment of Chronic MigraineStephen D Silberstein, David W Dodick, Marcelo E Bigal, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 9, 2015
Morphological Abnormalities of Thalamic Subnuclei in Migraine: A Multicenter MRI Study at 3 TeslaStefano Magon, Arne May, Anne Stankewitz, et al.Cephalalgia : an International Journal of Headache|June 1, 2019
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraineMessoud Ashina, Peter J Goadsby, Uwe Reuter, et al.The New England Journal of Medicine|July 11, 2019
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for MigraineRichard B Lipton, Robert Croop, Elyse G Stock, et al.Nature Medicine|May 12, 2025
Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trialPeter J Goadsby, Jessica Ailani, David W Dodick, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 2, 2013
Headache-related health resource utilisation in chronic and episodic migraine across six countriesJoanna C Sanderson, Emily B Devine, Richard B Lipton, et al.The Lancet. Neurology|March 9, 2010
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trialRichard B Lipton, David W Dodick, Stephen D Silberstein, et al.Neurology. Clinical Practice|October 14, 2024
Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening PeriodTodd J Schwedt, Richard B Lipton, Peter J Goadsby, et al.Neurology|August 17, 2022
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe PainRichard B Lipton, David W Dodick, Peter J Goadsby, et al.Pageof 54